Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Piper Sandler Maintains Overweight on Equity Bancshares, Raises Price Target to $38

Author: Benzinga Newsdesk | April 23, 2024 09:21am
Piper Sandler analyst Andrew Liesch maintains Equity Bancshares (NYSE:EQBK) with a Overweight and raises the price target from $37 to $38.

Posted In: EQBK

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist